Modulating AMPA receptors: Key to mild cognitive impairment and memory?

Drug Discovery Today

Volumn 5, Issue 10, 2000, Pages 441-442

  Sansom, Clare ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ALPHA TOCOPHEROL; AMPA RECEPTOR; DONEPEZIL;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MEMORY; MOUSE; NONHUMAN; RAT; RECALL; SHORT SURVEY;

EID: 0034307879     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01563-4     Document Type: Short Survey

References (7)

1. Arai A., Lynch G. Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation. Brain Res. 598:1992;173-184.
2. Staubli U.et al. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. U. S. A. 91:1994;777-781.
3. Staubli U.et al. Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11158-11162.
4. Staubli U.et al. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. U. S. A. 91:1994;777-781.
5. Hampson R.E.et al. Facilitative effects of the Ampakine CX516 on short-term memory in rats: enhancement of delayed nonmatch-to-sample performance. J. Neurosci. 18:1998;2740-2747.
6. Lynch G.et al. Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp. Neurol. 145:1997;89-92.
7. Petersen R.C.et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56:1999;303-308.